Review of Systems

Total Page:16

File Type:pdf, Size:1020Kb

Review of Systems Review of Systems Name:_____________________________________ DOB:_________________ Date:___________________ Sex:___________ Age:_________________ General None Yes No Lymph_ None Yes No Pain ▢ ▢ Yes No Fever ▢ ▢ Discharge ▢ ▢ Tender nodes ▢ ▢ Chills ▢ ▢ Other:________________________ Enlargement ▢ ▢ Malaise ▢ ▢ Other:________________________ Fatigue ▢ ▢ Ears None Night sweats ▢ ▢ Yes No Endocrine None Weight changes ▢ ▢ Hearing loss ▢ ▢ Yes No Other:________________________ Pain ▢ ▢ Heat/cold intolerance ▢ ▢ Discharge ▢ ▢ Weight change ▢ ▢ Diet None Vertigo ▢ ▢ Increased thirst ▢ ▢ Yes No Ringing in the ears ▢ ▢ Increased urination ▢ ▢ Appetite ▢ ▢ Other:________________________ Hair changes ▢ ▢ Restrictions ▢ ▢ Other:________________________ Vitamins ▢ ▢ Nose None Supplements ▢ ▢ Yes No Female None Other:________________________ Congestion ▢ ▢ Yes No Nose bleeds ▢ ▢ Changes in menses ▢ ▢ Skin, Hair & Nails None Postnasal drip ▢ ▢ Pain with intercourse ▢ ▢ Yes No Changes in smell ▢ ▢ New partners ▢ ▢ Rash ▢ ▢ Other:________________________ Changes in contraception ▢ ▢ Eruptions ▢ ▢ Menopausal symptoms ▢ ▢ Itching ▢ ▢ Throat & Mouth None LMP________________________ Pigment changes ▢ ▢ Yes No Other:________________________ Hair loss/changes ▢ ▢ Hoarseness ▢ ▢ New moles ▢ ▢ Sore throat ▢ ▢ Male None Lesions /sores ▢ ▢ Bleeding gums ▢ ▢ Yes No Other:________________________ Ulcers ▢ ▢ Puberty onset ▢ ▢ Tooth problems ▢ ▢ Erections ▢ ▢ Head & Neck None Difficulty swallowing ▢ ▢ Testicular pain ▢ ▢ Yes No Changes in voice ▢ ▢ Libido ▢ ▢ Headaches ▢ ▢ Other:________________________ Penile discharge ▢ ▢ Dizziness ▢ ▢ Testicular lumps ▢ ▢ Head injuries ▢ ▢ Gastrointestinal None Difficulty urinating ▢ ▢ Loss of consciousness ▢ ▢ Yes No Other:________________________ Other:________________________ Indigestion ▢ ▢ Heartburn ▢ ▢ Breasts None Eyes None Vomiting ▢ ▢ Yes No Yes No Bowel reg/changes ▢ ▢ Pain ▢ ▢ Blurring ▢ ▢ Nausea ▢ ▢ Tenderness ▢ ▢ Double vision ▢ ▢ Belching ▢ ▢ Lumps ▢ ▢ Glasses ▢ ▢ Flatulence ▢ ▢ Nipple discharge ▢ ▢ Trauma ▢ ▢ Blood in stool ▢ ▢ Skin/pigment changes ▢ ▢ Irritation ▢ ▢ Other:________________________ Other:________________________ Review of Systems continued, pg 2 Name:_____________________________________ Chest & Lungs None Mental Status No ne Result:_________________________ Yes No Yes No Cough ▢ ▢ Loss concentration ▢ ▢ Follow-up:_____________________ Sputum ▢ ▢ Difficulty sleeping ▢ ▢ Shortness of breath ▢ ▢ Mood changes ▢ ▢ Other:________________________ Wheezing ▢ ▢ Suicidal thoughts ▢ ▢ Night sweats ▢ ▢ Anxiety ▢ ▢ ______________________________ Exposure to TB ▢ ▢ Other:_________________________ Other:________________________ ______________________________ Neurological None Cardiovascular None Loss of strength▢ ▢ ______________________________ Yes No Tingling/Numbness ▢ ▢ Chest pain ▢ ▢ Headaches ▢ ▢ ______________________________ Palpations ▢ ▢ Lightheaded ▢ ▢ Leg or ankle swelling ▢ ▢ Seizures ▢ ▢ Leg pain/cramps Tremors/shaking ▢ ▢ with walking ▢ ▢ Decreased use of limb ▢ ▢ Comments:_____________________ Exercise intolerance ▢ ▢ Memory loss ▢ ▢ # of pillows needed to sleep_______ Confusion ▢ ▢ ______________________________ Other:_________________________ Other:_________________________ ______________________________ Hematology None Health Habits None Yes No Yes No ______________________________ Anemia ▢ ▢ Tobacco ▢ ▢ Easy bruising ▢ ▢ Alcohol ▢ ▢ ______________________________ Other:_________________________ Drugs ▢ ▢ Exercise ▢ ▢ ______________________________ Genitourinary None Exposure to chemicals ▢ ▢ Yes No Other:_________________________ ______________________________ Pain with urination ▢ ▢ Flank pain ▢ ▢ Health Maintenance None ______________________________ Urgency ▢ ▢ Yes No Frequency ▢ ▢ Self exams: Blood in urine ▢ ▢ breast ▢ ▢ Signature: Dribbling/incontinence ▢ ▢ genital ▢ ▢ Getting up at night testicular ▢ ▢ ______________________________ to urinate ▢ ▢ # of times_______________ Last PE________________________ Date: Other:_________________________ ______________________________ Last pap smear__________________ Musculoskeletal None Last mammogram________________ Yes No Joint pain ▢ ▢ Diagnostic tests Yes No Heat ▢ ▢ ______________________________ Swelling ▢ ▢ Weakness ▢ ▢ ______________________________ Loss of coordination ▢ ▢ Loss of mobility ▢ ▢ Date:__________________________ Other:_________________________.
Recommended publications
  • 2.04.26 Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Irritable Bowel Syndrome
    MEDICAL POLICY – 2.04.26 Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Irritable Bowel Syndrome BCBSA Ref. Policy: 2.04.26 Effective Date: July 1, 2021 RELATED MEDICAL POLICIES: Last Revised: June 8, 2021 None Replaces: N/A Select a hyperlink below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE REVIEW | REFERENCES | HISTORY ∞ Clicking this icon returns you to the hyperlinks menu above. Introduction Intestinal dysbiosis is a condition that occurs when the microorganisms in the digestive tract are out of balance. This condition is believed to cause diseases of the digestive tract, including poor nutrient absorption, overgrowth of certain bacteria, and irritable bowel syndrome (IBS). Symptoms of these digestive problems are similar and may include: abdominal pain, excess gas, bloating, and changes in bowel movements (constipation or diarrhea, or both). One method of diagnosing digestive disorders is by testing a fecal sample. Using fecal analysis to diagnose intestinal dysbiosis, IBS, malabsorption, or small intestinal overgrowth of bacteria is unproven (investigational). More studies are needed to see if this testing improves health outcomes. Note: The Introduction section is for your general knowledge and is not to be taken as policy coverage criteria. The rest of the policy uses specific words and concepts familiar to medical professionals. It is intended for providers. A provider can be a person, such as a doctor, nurse, psychologist, or dentist. A provider also can be a place where medical care is given, like a hospital, clinic, or lab. This policy informs them about when a service may be covered.
    [Show full text]
  • Review of Systems Form
    Child’s name or label Since the last visit, how are your child’s symptoms? Better? Worse? The same? Please describe: Any new health problems, consultations, ER visits, hospital admissions, procedures or surgeries since your last visit? None Evaluations or tests done since the last visit: MRI EEG Blood work Child Study Team evaluation Neuropsychological testing ImPACT test Audiology Nutritionist consultation Questionnaires Physician Consultations:______________________ Other: ____________________ None If your child takes medications, please list the medications and doses here: 1.__________________________________________________ 4.__________________________________________ 2._________________________________________________ 5._________________________________________ 3.__________________________________________________ 6.__________________________________________ PEDS NEURO REVIEW OF SYSTEMS: Please list symptoms your child has since the last visit. Describe “yes” responses. NEUROLOGICAL KNOWN EYE CONDITIONS YES NO ___________________ HYPERACTIVITY YES NO ___________________ EAR, NOSE AND THROAT SEIZURES YES NO ___________________ HEARING LOSS OR DEFICIT YES NO ___________________ FAINTING YES NO ___________________ SLEEP APNEA YES NO ___________________ SNORING YES NO ___________________ CARDIOVASCULAR HEADACHES YES NO ___________________ RAPID OR IRREGULAR HEART BEAT YES NO ___________________ TICS YES NO ___________________ CHEST PAIN OR EXERCISE INTOLERANCE YES NO ___________________ INATTENTION
    [Show full text]
  • NIH Public Access Author Manuscript Auton Neurosci
    NIH Public Access Author Manuscript Auton Neurosci. Author manuscript; available in PMC 2016 March 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Auton Neurosci. 2015 March ; 188: 86–89. doi:10.1016/j.autneu.2014.11.008. Exercise in the Postural Orthostatic Tachycardia Syndrome Qi Fu and Benjamin D. Levine Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, The University of Texas Southwestern Medical Center, Dallas, TX, USA Abstract Patients with the Postural Orthostatic Tachycardia Syndrome (POTS) have orthostatic intolerance, as well as exercise intolerance. Peak oxygen uptake (VO2peak) is generally lower in these patients compared with healthy sedentary individuals, suggesting a lower physical fitness level. During acute exercise, POTS patients have an excessive increase in heart rate and reduced stroke volume for each level of absolute workload; however, when expressed at relative workload (%VO2peak), there is no difference in the heart rate response between patients and healthy individuals. The relationship between cardiac output and VO2 is similar between POTS patients and healthy individuals. Short-term (i.e., 3 months) exercise training increases cardiac size and mass, blood volume, and VO2peak in POTS patients. Exercise performance is improved after training. Specifically, stroke volume is greater and heart rate is lower at any given VO2 during exercise after training versus before training. Peak heart rate is the same but peak stroke volume and cardiac output are greater after training. Heart rate recovery from peak exercise is significantly faster after training, indicating an improvement in autonomic circulatory control. These results suggest that patients with POTS have no intrinsic abnormality of heart rate regulation during exercise.
    [Show full text]
  • Pulmonary Hypertension and Exercise Intolerance in Patients with Heart Failure Javed Butler, MD, Don B
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Journal of the American College of Cardiology Vol. 34, No. 6, 1999 © 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00408-8 Pulmonary Hypertension and Exercise Intolerance in Patients With Heart Failure Javed Butler, MD, Don B. Chomsky, MD, John R. Wilson, MD, FACC Nashville, Tennessee OBJECTIVES This study was undertaken to investigate the relationship between pulmonary hypertension and exercise performance in patients with heart failure. BACKGROUND The exercise capacity of patients with heart failure is frequently reduced. Pulmonary hypertension may contribute to this exercise intolerance by impairing blood flow through the pulmonary circulation. METHOD Three hundred twenty patients with heart failure underwent upright treadmill exercise testing with hemodynamic monitoring. The incidence of pulmonary hypertension and the relation- ship between pulmonary vascular resistance (PVR) and exercise cardiac output and minute oxygen consumption (VO2) were examined. RESULTS Pulmonary vascular resistance was normal (Ͻ1.5 Wood Units; Group 1) in 28% of the patients, mildly elevated (1.5 to 2.49 Wood Units; Group 2) in 36%, moderately elevated (2.5 to 3.49 Wood Units; Group 3) in 17% and severely elevated (Ͼ3.5 Wood Units; Group 4) in 19%. Increasing PVR was associated with significantly lower peak exercise VO2 (Group 1: 13.9 Ϯ 3.7; 2:13.7 Ϯ 3.4; 3: 11.8 Ϯ 2.4; 4: 11.5 Ϯ 2.6 L/min, p Ͻ 0.01 Groups 3 and 4 vs.
    [Show full text]
  • Impact of Atrial Fibrillation on Exercise Capacity And
    ORIGINAL RESEARCH Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing Mohamed B. Elshazly, MD; Todd Senn, MD; Yuping Wu, PhD; Bruce Lindsay, MD; Walid Saliba, MD; Oussama Wazni, MD; Leslie Cho, MD Background-—Atrial fibrillation (AF) has been objectively associated with exercise intolerance in patients with heart failure with reduced ejection fraction; however, its impact in patients with heart failure with preserved ejection fraction has not been fully scrutinized. Methods and Results-—We identified 1744 patients with heart failure and ejection fraction ≥50% referred for cardiopulmonary stress testing at the Cleveland Clinic (Cleveland, OH), 239 of whom had AF. We used inverse probability of treatment weighting to balance clinical characteristics between patients with and without AF. A weighted linear regression model, adjusted for unbalanced variables (age, sex, diagnosis, hypertension, and b-blocker use), was used to compare metabolic stress parameters and 8-year total mortality (social security index) between both groups. Weighted mean ejection fraction was 58Æ5.9% in the entire population. After adjusting for unbalanced weighted variables, patients with AF versus those without AF had lower mean peak oxygen consumption (18.5Æ6.2 versus 20.3Æ7.1 mL/kg per minute), oxygen pulse (12.4Æ4.3 versus 12.9Æ4.7 mL/beat), and circulatory power (2877Æ1402 versus 3351Æ1788 mm HgÁmL/kg per minute) (P<0.001 for all comparisons) but similar submaximal exercise capacity (oxygen consumption at anaerobic threshold, 12.0Æ5.1 versus 12.4Æ6.0mL/kg per minute; P =0.3). Both groups had similar peak heart rate, whereas mean peak systolic blood pressure was lower in the AF group (150Æ35 versus 160Æ51 mm Hg; P<0.001).
    [Show full text]
  • Statewide Heart Failure Service, Heart Failure Daily Diary
    Available online at www.sciencedirect.com Journal of Science and Medicine in Sport 13 (2010) 288–294 Position statement Exercise & Sports Science Australia Position Statement on exercise training and chronic heart failure Steve E. Selig a,b,∗, Itamar Levinger a,b, Andrew D. Williams c, Neil Smart d, David J. Holland e, Andrew Maiorana f,g, Daniel J. Green h,i, David L. Hare b,j a Institute for Sport, Exercise and Active Living, School of Sport and Exercise Science, Victoria University, Melbourne, Australia b Department of Cardiology, Austin Health, Melbourne, Australia c School of Human Life Sciences, University of Tasmania, Tasmania, Australia d Faculty of Health Science and Medicine, Bond University, QLD, Australia e School of Medicine, University of Queensland, Brisbane, Australia f Cardiac Transplant Unit, Royal Perth Hospital, Australia g School of Physiotherapy, Curtin University of Technology, Australia h School of Sport Science, Exercise and Health, University of Western Australia, Australia i Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, United Kingdom j School of Medicine, University of Melbourne, Australia Received 18 September 2009; received in revised form 18 January 2010; accepted 19 January 2010 Abstract Chronic heart failure (CHF) is a complex syndrome characterised by progressive decline in left ventricular function, low exercise tolerance and raised mortality and morbidity. Regular exercise participation has been shown to be a safe and effective treatment modality in the majority of CHF patients, partially reversing some of the maladaptations evident in myocardial and skeletal muscle function, and resulting in improvements in physical fitness and quality of life, and perhaps reduced mortality.
    [Show full text]
  • An Osteopathic Approach to Reduction of Readmissions for Neonatal Jaundice
    Osteopathic Family Physician (2013) 5, 17–23 REVIEW ARTICLE An osteopathic approach to reduction of readmissions for neonatal jaundice Rachel Click, DO,a Julie Dahl-Smith, DO,a Lindsay Fowler, DO,a Jacqueline DuBose, MD,a Margi Deneau-Saxton, RN, CCCE, CIMI, CLC, CPD,b Jennifer Herbert, MDc From aGeorgia Health Sciences University, Medical College of Georgia, Department of Family Medicine, GA; bGeorgia Health System, OB Labor and Delivery, GA; and cUniversity Primary Care, Evans, GA. KEYWORDS: Jaundice is a potentially life-threatening condition that continues to affect at-risk newborns, accounting Breastfeeding; for continued hospital readmissions. As family physicians, we should be cognizant of neonates who may Jaundice; be at risk for jaundice, including those with pathologic jaundice as well as newborns of breastfeeding Prevention; mothers, and ensure sufficient intervention is taken to help prevent further elevations in bilirubin levels. Hyperbilirubinemia; Interventions are likely to include evaluation for sepsis, education regarding feeding frequencies for both Neonatal massage breast- and bottle-fed neonates, reviewing maternal and hematologic risk factors for neonatal jaundice, and considering inborn errors of metabolism. An additional measure family physicians may consider is that of neonatal massage for those with elevated bilirubin levels. Neonatal massage, though not widely used, has been proven to promote excess bilirubin excretion, thus decreasing length of hospital stay; all the while, providing an intervention that allows parents to take an active role. r 2013 Elsevier Inc. All rights reserved. Introduction morbidity rate with bilirubin 4 20 mg/dL. “It has been estimated that the risk of kernicterus in infants with total Jaundice is a product of excess bilirubin (a product of serum bilirubin (TSB) greater than 30 mg/dL is about 1 in broken down red blood cells), which manifests as a 7 infants”.1 Less serious complications of hyperbilirubine- yellowing of the skin and eyes.
    [Show full text]
  • INFORMED CARING JAUNDICE Neonatal Jaundice BILIARY
    1 INFORMED CARING Situations with Adults and Children with Gallbladder, Liver and Pancreatic Disorders 2 JAUNDICE ä Does NOT mean hepatitis ä Increased breakdown of RBCs ä Altered bilirubin breakdown ä Impeded flow through liver or bile duct ä First seen in sclera, then skin 3 Neonatal Jaundice ä Not liver failure ä RBC breakdown ä Phototherapy 4 BILIARY ATRESIA ä Jaundice 2-3 weeks after birth ä Easy bruising ä Stools putty like ä Tea colored urine ä Abdominal/organ distension 5 4 F’s of Gallbladder ä Fair ä Fat X size of person X amount in diet ä Fertile X BCP X Multiparity ä Forty 6 Cholelithiasis ä Calculi within the duct or gallbladder ä Severe colicky, cramp-like pain X radiates to shoulder blade X Murphy's sign ä Cholecystitis: inflammation X Can be caused by trauma, fasting, TPN or abdominal surgery 7 Diagnostic Studies ä Ultrasound of abdomen 1 X not for the obese ä HIDA scan X nuclear medicine ä Cholangiograms X endoscopic X transvenous X intraoperative 8 Post-op Care ä High abdominal incision X respiratory compromise ä T-tube X patients need to know how to empty it X may clamp it prior to removal X caution not dislodged with movements ä NO Morphine X spasms of sphincter of Oddi 9 Post-op Nutrition ä Limited fat in diet X can have rapid transit times ä Potential fat soluble vitamin deficit X A, D, E and K ä Weight loss diet 10 LIVER FAILURE ä Cirrhosis ä Drug toxicity X acetaminophen, anesthetics, HCTZ, chemotherapy ä Infection ä Cancer ä ETOH is single most linked cause 11 LIVER FAILURE S/S ä Don’t show up until 80-90% failed
    [Show full text]
  • Review of Systems Health History Sheet Patient: ______DOB: ______Age: ______Gender: M / F
    603 28 1/4 Road Grand Junction, CO 81506 (970) 263-2600 Review of Systems Health History Sheet Patient: _________________ DOB: ____________ Age: ______ Gender: M / F Please mark any symptoms you are experiencing that are related to your complaint today: Allergic/ Immunologic Ears/Nose/Mouth/Throat Genitourinary Men Only Frequent Sneezing Bleeding Gums Pain with Urinating Pain/Lump in Testicle Hives Difficulty Hearing Blood in Urine Penile Itching, Itching Dizziness Difficulty Urinating Burning or Discharge Runny Nose Dry Mouth Incomplete Emptying Problems Stopping or Sinus Pressure Ear Pain Urinary Frequency Starting Urine Stream Cardiovascular Frequent Infections Loss of Urinary Control Waking to Urinate at Chest Pressure/Pain Frequent Nosebleeds Hematologic / Lymphatic Night Chest Pain on Exertion Hoarseness Easy Bruising / Bleeding Sexual Problems / Irregular Heart Beats Mouth Breathing Swollen Glands Concerns Lightheaded Mouth Ulcers Integumentary (Skin) History of Sexually Swelling (Edema) Nose/Sinus Problems Changes in Moles Transmitted Diseases Shortness of Breath Ringing in Ears Dry Skin Women Only When Lying Down Endocrine Eczema Bleeding Between Shortness of Breath Increased Thirst / Growth / Lesions Periods When Walking Urination Itching Heavy Periods Constitutional Heat/Cold Intolerance Jaundice (Yellow Extreme Menstrual Pain Exercise Intolerance Gastrointestinal Skin or Eyes) Vaginal Itching, Fatigue Abdominal Pain Rash Burning or Discharge Fever Black / Tarry Stool Respiratory Waking to Urinate at Weight Gain (___lbs) Blood
    [Show full text]
  • Symptomatic Approach to Gas, Belching and Bloating 21
    20 Osteopathic Family Physician (2019) 20 - 25 Osteopathic Family Physician | Volume 11, No. 2 | March/April, 2019 Gennaro, Larsen Symptomatic Approach to Gas, Belching and Bloating 21 Review ARTICLE to escape. This mechanism prevents the stomach from becoming IRRITABLE BOWEL SYNDROME (IBS) Symptomatic Approach to Gas, Belching and Bloating damaged by excessive dilation.2 IBS is abdominal pain or discomfort associated with altered with OMT Treatment Options Many patients with GERD report increased belching. Transient bowel habits. It is the most commonly diagnosed GI disorder lower esophageal sphincter (LES) relaxation is the major and accounts for about 30% of all GI referrals.7 Criteria for IBS is recurrent abdominal pain at least one day per week in the Carly Gennaro, DO1; Helaine Larsen, DO1 mechanism for both belching and GERD. Recent studies have shown that the number of belches is related to the number of last three months associated with at least two of the following: times someone swallows air. These studies have concluded that 1) association with defecation, 2) change in stool frequency, 1 Good Samaritan Hospital Medical Center, West Islip, NY patients with GERD swallow more air in response to heartburn and 3) change in stool form. Diagnosis should be made using these therefore belch more frequently.3 There is no specific treatment clinical criteria and limited testing. Common symptoms are for belching in GERD patients, so for now, physicians continue to abdominal pain, bloating, alternating diarrhea and constipation, treat GERD with proton pump inhibitors (PPIs) and histamine-2 and pain relief after defecation. Pain can be present anywhere receptor antagonists with the goal of suppressing heartburn and in the abdomen, but the lower abdomen is the most common KEYWORDS: ABSTRACT: Intestinal gas production is a normal physiologic progress.
    [Show full text]
  • Patient Review of Systems Please Mark Any Condition with Which You Have Had Significant Problems in the Last 6 Months
    Date of appointment: ________________________ Patient name: ____________________________________________ Date of birth: _________________ Age: ___________ Primary care provider: _____________________________________ Referring provider: ___________________________________ Reason for Visit: _____________________________________________________________________________________________ *Nurse use only: Preferred local pharmacy: _______________________________ Preferred mail order pharmacy: _______________________ Preferred laboratory for blood work: ______________________ Preferred radiology facility: ___________________________ HT _______ Weight _______ BP ______/______ Pulse ________ Immunizations: Flu/When?_____ (65 or older) Pneumovax/When?_____ Fallen within the last 3 months? ______ Fear of falling?______ Difficulty ambulating? ______ Patient Review of Systems Please mark any condition with which you have had significant problems in the last 6 months: Constitution Gastrointestinal Skin ___ Chills ___ Abdominal distention ___ Rash ___ Diaphoresis (Night sweats) ___ Abdominal pain ___ Color changes (Yellow skin) ___ Fatigue ___ Blood in stool ___ Fever ___ Constipation ___ Loss of appetite ___ Diarrhea Neurological ___ Weight loss ___ Nausea ___ Dizziness ___ Weight gain ___ Vomiting ___ Headaches ___ Black stool ___ Light-headedness HEENT ___ Change in bowel habits ___ Seizures ___ Eye pain ___ Difficulty swallowing ___ Weakness ___ Trouble swallowing ___ Gas/flatulence ___ Yellow eyes ___ Heartburn/indigestion ___ Bowel accidents Hematological
    [Show full text]
  • Traveller's Diarrhoea (TD) Is the Commonest Health
    Diarrhoea • THEME Traveller's diarrhoea BACKGROUND There has been little if any Traveller's diarrhoea (TD) is the commonest health change in the incidence of traveller's diarrhoea problem facing travellers to less developed countries over the past 20 years. of the world. It is costly to both the traveller (time lost) and the host country (eg. cancelled activities). OBJECTIVE This article aims to provide a basic understanding on why travellers are more likely to Definition experience diarrhoea during travel. Classic TD is described as three or more loose bowel DISCUSSION In a 20 minute pretravel actions with at least one of the following accompanying consultation time is precious, and providing symptoms: nausea, vomiting, abdominal cramps or information on traveller's diarrhoea often has pain, fever or blood in the stools. Lesser degrees a low priority over prescribing the necessary vaccinations and discussing antimalarials. (moderate or mild) of TD are also described. Severity is Bob Kass, Travellers do not follow the rules of eating and usually defined by the number of bowel actions per 24 drinking safely, and diarrhoea is common. 'What hour period (severe >6). According to the World Health MBBS, MRCP (UK), MScMCH, Organisation, symptoms lasting less than 14 days may to do in the event of illness' is an important DCH, FAFPHM, consideration. Presumptive treatment should be defined as 'acute diarrhoea', and those lasting more is a consultant, be offered to all travellers whose itinerary and than 14 days 'persistent diarrhoea'.1 International Public activities put them at risk. Between 30 and 50% of travellers will be affected Health Medicine, Rede-Health in a 2 week overseas stay, with approximately 12% International.
    [Show full text]